We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More
Free Medical Devices WebinarsSign up to watch our free medical devices industry webinars. 
Henry Schein Medical, the US medical business of Henry Schein announced today its new private label-branded product, OneStep + Pro Hb Analyzer, a portable, reagent-free hemoglobin analyzer, which measures hemoglobin concentration as a result of a fingerstick blood test.
Boston-based biomedical software company BostonGene has secured a $50m Series A strategic investment from Tokyo-based IT services and products provider NEC to support scaling and precision medicine computing platform for cancer treatment.
Roche has introduced new Ventana HER2 Dual ISH DNA Probe Cocktail assay to detect HER2 biomarker in breast and gastric cancer patients.
Medical technology firm Hologic has secured CE IVD mark for ThinPrep Genesis processor for cytology slide and molecular test preparation.
Molecular diagnostics technology company Co-Diagnostics has inaugurated its Indian joint venture facility for manufacturing in Ranoli, India.
Bruker has announced new assays, software and library extensions for its MALDI Biotyper, IR Biotyper and Fluorocycler XT product lines for microbial identification, infection control and molecular diagnostics of infectious diseases.
Bluejay Diagnostics has secured CE Mark for its Allereye Tear Total IgE Test, a non-invasive, point-of-care (POC) test for allergic conjunctivitis.
Aggredyne has received US Food and Drug Administration (FDA) clearance for its AggreGuide A‑100 ADP Assay testing cartridge, an in vitro diagnostic device for measuring the effect of various antiplatelet medications that target the platelet P2Y12 receptor.
Epic Sciences and its research partners report the use of the company's new circulating tumor cell (CTC) homologous recombination deficiency (HRD) liquid biopsy assay for the prediction of drug resistance in patients with metastatic castration-resistant prostate cancer (mCRPC).
Antimicrobial Barrier Caps manufacturer Pursuit Vascular has received both Conformité Européene (CE) Mark and Medical Device Single Audit Program (MDSAP) certificates for its ClearGuard HD caps, making the way clear for launch in international markets.
Get the Medical Devices newsletterSign up to our free email to get all the latest medical devices news.